Stock analysis, AI verdict, fundamentals & technical signals
Rating: BUY
Price: $1.80 Analyst target: $8.83 Upside: 390.56%
Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company is headquartered in Princeton, New Jersey.
See the full interactive analysis & chart →Informational only — not investment advice.